North America HLA Typing Transplant Diagnostics Services Market – Industry Trends and Forecast to 2025

  • Biotech And Research
  • Published Report
  • Mar 2018
  • North America
  • 84 Pages
  • No of Tables: 67
  • No of Figures: 66

North America HLA Typing Transplant Diagnostics Services Market, By Technology (Polymerase Chain Reaction {PCR-SSP, PCR SSOP, PCR-SBT}, Next-Generation Sequencing), End-User (Hospitals, Transplant Centers, Specialty Clinics, Academic Institutes), Country (U.S., Canada, Mexico)–Industry Trends and Forecast to 2025

North America HLA Typing Transplant Diagnostics Services Market is expected to reach USD 474.83 million by 2025, from USD 242.82 million in 2017 growing at a CAGR of 8.8% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.The major factors driving the growth of this market are technological advancements in HLA typing, increasing number of solid organ and stem cell transplantation procedures, increased research grants, funds, and public-private investments are boosting the growth of the North America HLA typing transplant diagnostics services market. On the other hand, weak reimbursements for organ donation and transplantation procedures, expensive NGS and PCR-based devices may hinder the growth of the market.

Market Segmentation: North America HLA Typing Transplant Diagnostics Services Market 

  • The North America HLA typing transplant diagnostics services market is segmented based on technology into polymerase chain reaction (PCR), and next-generation sequencing (NGS). In 2018, polymerase chain reaction (PCR) segment is expected to dominate the North America HLA typing transplant diagnostics services market with 52.0% market share and is expected to reach USD 242.58 million by 2025, with a CAGR of 8.6% in the forecast period 2018 to 2025. However, Next-Generation Sequencing (NGS) is expected to grow at the highest CAGR of 9.1% in the forecast period, and is expected to reach USD 232.25 million in 2025 from USD 116.16 million in 2017.
  • The polymerase chain reaction (PCR) is further sub segmented on the basis of techniques into PCR-SSP (Sequence-Specific Primer), PCR SSOP (Sequence-Specific Oligonucleotide), and PCR-SBT (Sequencing Based Typing). In 2018, PCR-SSP (Sequence-Specific Primer) segment is expected to dominate the North America HLA typing transplant diagnostics services market with 43.3% market share and is expected to reach USD 199.66 million by 2025, with the CAGR of 8.4% in the forecast period 2018 to 2025. However, PCR-SBT (Sequencing Based Typing) segment is expected to grow at the highest CAGR of 9.4% in the forecast period, and is expected to reach USD 94.48 million in 2025 from USD 46.32 million in 2017.
  • The North America HLA typing transplant diagnostics services market is segmented on the basis of end users into hospitals, transplant centers, specialty clinics, and academic institutes. In 2018, hospitals segment is expected to dominate the North America HLA typing transplant diagnostics services market with 37.8% market share and is expected to reach USD 185.24 million by 2025, with the highest CAGR of 9.3% in the forecast period 2018 to 2025.

Key Drivers: North America HLA Typing Transplant Diagnostics Services Market

Some of the major factors driving the market for North America HLA typing transplant diagnostics services market are technological advancements in HLA typing, increasing number of solid organ and stem cell transplantation procedures, risen research grants, funds, and public-private investments are boosting the growth of the North America HLA typing transplant diagnostics services market.

On the other hand, weak reimbursements for organ donation and transplantation procedures, expensive NGS and PCR-based devices may hinder the growth of the market.

Key Points: North America HLA Typing Transplant Diagnostics Services Market

One Lambda (Thermo Fischer Scientific, InC.) is going to dominate the North America HLA typing transplant diagnostics services market followed by Proimmune Ltd., Creative Biolabs, Histogenetics LLC, The UCLA Immunogenetics Center, Admera Health, Quick Biology, New York Blood Center, The Sequencing Center, BloodCenter of Wisconsin, and Laboratory Corporation of America Holdings

  • The polymerase chain reaction (PCR) segment is dominating the North America HLA typing transplant diagnostics services market.
  • The next generation sequencing (NGS) segment is expected to grow with the highest CAGR of 9.1% in the forecast period 2018 to 2025.

SKU-

TABLE LIST NORTH AMERICA HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET

TABLE 1 COST OF DIFFERENT NGS DEVICES

TABLE 2 NORTH AMERICA HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET, BY TECHNOLOGY, 2016– 2025 (USD MILLION)

TABLE 3 NORTH AMERICA HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET, NEXT-GENERATION SEQUENCING (NGS), BY REGION, 2016 – 2025 (USD MILLION)

TABLE 4 NORTH AMERICA HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET, POLYMERASE CHAIN REACTION (PCR), BY TECHNIQUE, 2016-2025 (USD MILLION)

TABLE 5 NORTH AMERICA HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET, POLYMERASE CHAIN REACTION (PCR), BY REGION, 2016 – 2025 (USD MILLION)

TABLE 6 NORTH AMERICA HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET, BY END-USER, 2016-2025 (USD MILLION)

TABLE 7 NORTH AMERICA HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET, SPECIALTY CLINICS, BY REGION, 2016 – 2025 (USD MILLION)

TABLE 8 NORTH AMERICA HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET, HOSPITALS, BY REGION, 2016 – 2025 (USD MILLION)

TABLE 9 NORTH AMERICA HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET, TRANSPLANT CENTERS, BY REGION, 2016 – 2025 (USD MILLION)

TABLE 10 NORTH AMERICA HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET, ACADEMIC INSTITUTES, BY REGION, 2016 – 2025 (USD MILLION)

TABLE 11 NORTH AMERICA HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET, BY COUNTRY, 2016-2025 (USD MILLION)

TABLE 12 NORTH AMERICA HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET BY TECHNOLOGY, 2016 - 2025 (USD MILLION)

TABLE 13 NORTH AMERICA POLYMERASE CHAIN REACTION (PCR) MARKET , BY TECHNIQUE, 2016 - 2025 (USD MILLION)

TABLE 14 NORTH AMERICA HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET BY END-USER, 2016 - 2025 (USD MILLION)

TABLE 15 U.S. HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET , BY TECHNOLOGY, 2016 - 2025 (USD MILLION)

TABLE 16 U.S. POLYMERASE CHAIN REACTION (PCR) MARKET , BY TECHNIQUE, 2016 - 2025 (USD MILLION)

TABLE 17 U.S. HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET , BY END-USER, 2016 - 2025 (USD MILLION)

TABLE 18 CANADA HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET , BY TECHNOLOGY, 2016 - 2025 (USD MILLION)

TABLE 19 CANADA POLYMERASE CHAIN REACTION (PCR) MARKET , BY TECHNIQUE, 2016 - 2025 (USD MILLION)

TABLE 20 CANADA HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET , BY END-USER, 2016 - 2025 (USD MILLION)

TABLE 21 MEXICO HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET , BY TECHNOLOGY, 2016 - 2025 (USD MILLION)

TABLE 22 MEXICO POLYMERASE CHAIN REACTION (PCR) MARKET , BY TECHNIQUE, 2016 - 2025 (USD MILLION)

TABLE 23 MEXICO HLA TYPING TRANSPLANT DIAGNOSTICS SERVICES MARKET , BY END-USER, 2016 - 2025 (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19